Multiply Labs Unveils First Peer-Reviewed Study Showing that Robotic Cell Expansion Can Match the Performance and Reduce the Costs of a Manual Process
View the full release here: https://www.businesswire.com/news/home/20240326888217/en/
- View the full release here: https://www.businesswire.com/news/home/20240326888217/en/
The paper, “ Development of a robotic cluster for automated and scalable cell therapy manufacturing ,” found that during the expansion phase of T cells-based therapy, Multiply Labs’ robotic system can automate an existing manual process while maintaining statistical equivalence on all critical process parameters. - In fact, as much as 50% of manufacturing costs stem from labor-intensive manual processes and a shortage of skilled workers.
- A key advantage of Multiply Labs’ robotic technology is its compatibility with leading cell therapy manufacturing instruments.
- The data in this study shows that it is possible to automate an existing cell expansion protocol without significantly changing the process or impacting product characteristics.